Brello Health
Brello Health is a Houston-based direct-to-consumer telehealth platform that connects women with healthcare providers for prescribed longevity medications, including compounded GLP-1s, NAD+, and Sermorelin, paired with a digital wellness studio, mobile app, and community support.
- Company typePrivate
- Founded2023
- HeadquartersHouston, United States
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Brello Health does
Brello Health (legal entity Brello, LLC) is a Houston-based, direct-to-consumer telehealth platform founded in 2023 that serves women seeking longevity and weight-management solutions. The company connects customers with licensed healthcare providers via online intake, then prescribes and ships compounded wellness medications — primarily Tirzepatide and Semaglutide (GLP-1 agonists), NAD+, and Sermorelin — through a single 503A partner pharmacy (AP Max, Inc. d/b/a Southend Pharmacy). The operating footprint is US-only, with a real-time state-availability map indicating phased geographic rollout.
The product surface combines medication subscriptions with a surrounding wellness ecosystem. Core technology comprises a web-based telehealth platform (app.brellohealth.com), native iOS and Android applications (Brello App) for progress tracking, provider messaging, dosage logging, refill reminders, and live shipping status, plus the Brello Rise digital wellness studio distributed across Apple TV, Fire TV, Roku TV, and Google TV. A private Facebook community ("Brello Thrive Together") and the Project Longevity six-episode podcast (debuting April 2026 on Spotify, Apple Podcasts, Amazon Music, and YouTube) extend member engagement. Pricing is published publicly across nine tiers ranging from $79/month (NAD+ standalone) to $299/month (The Longevity Stack: GLP-1 + NAD+ + Sermorelin), billed every 10 weeks under a 3-month minimum commitment.
Revenue mechanics are recurring subscription-based, supplemented by pass-through professional and pharmacy fees. The company reports 80,000+ active members, a marketing mix spanning content, podcast, email, paid social, and Trustpilot-driven word-of-mouth, and an active careers page via ADP suggesting continued hiring. The website explicitly flags that compounded drug products are not FDA-approved, which is a material regulatory disclosure for the category.
Brello Health firmographics
Firmographics- Name
- Brello Health
- Legal name
- Brello, LLC
- Website
- https://brellohealth.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Brello Health is a Houston-based direct-to-consumer telehealth platform that connects women with healthcare providers for prescribed longevity medications, including compounded GLP-1s, NAD+, and Sermorelin, paired with a digital wellness studio, mobile app, and community support.
- Ownership category
- akta.pro rank
Brello Health industry classification
Industry- Product category
- Telehealth Wellness Services
- NAICS
- Pharmacies and Drug Retailers (456110)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)
- akta.pro secondary industry
- Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)
Keywords
Where Brello Health is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Brello Health business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Wellness Medication Subscriptions: Monthly subscription plans for compounded GLP-1 medications (Tirzepatide, Semaglutide), NAD+, and Sermorelin. Plans require 3-month minimum commitments and are billed every 10 weeks. Medication is prescribed by healthcare providers following telehealth consultation.
- Bundled Care Plans: Comprehensive longevity protocols combining multiple medications (GLP-1 + NAD+, GLP-1 + NAD+ + Sermorelin) at discounted bundle pricing. Higher price points with all-inclusive approach including fitness classes and community access.
- Professional Fees: Clinical encounter fees (Provider Fee) and pharmacy service fees (Pharmacy Fee) charged prior to consultation and medication receipt. Fees are passed through to providers and pharmacy partners.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Tirzepatide - Compounded GLP-1 medication with B6 support |
| Subscription | Multi-year contract | Semaglutide - Compounded GLP-1 medication |
| Subscription | Multi-year contract | NAD+ - Cellular energy and longevity support |
| Subscription | Multi-year contract | Sermorelin - Peptide therapy |
| Subscription | Multi-year contract | Empowered+ GLP-1 + NAD+ Bundle |
| Subscription | Multi-year contract | The Longevity Stack - GLP-1 + NAD+ + Sermorelin |
| Subscription | Multi-year contract | Tirzepatide & NAD+ 3 Month Plan |
| Subscription | Multi-year contract | Semaglutide & NAD+ 3 Month Plan |
| Subscription | Multi-year contract | Lumen Metabolism Tracker Plan |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
Brello Health product offering
Product offeringCore offering
Brello Health operates a direct-to-consumer telehealth platform that connects women with healthcare providers for clinician-prescribed compounded wellness medications, primarily GLP-1 agonists (Tirzepatide and Semaglutide), NAD+, and Sermorelin, which are shipped from a USA-based 503A partner pharmacy directly to the customer's door. The service is bundled with a mobile app for progress tracking and provider messaging, a digital wellness studio (Brello Rise) for virtual fitness and nutrition classes on major streaming platforms, and a private Facebook community for ongoing accountability.
Product overview
Brello Health is a direct-to-consumer women's longevity health brand founded in 2023, operating as a telehealth platform that connects women with healthcare providers for wellness medications delivered to their door with ongoing support. The product portfolio centers on GLP-1 medications (Tirzepatide and Semaglutide) for weight management, combined with longevity-focused compounds (NAD+ and Sermorelin). These are offered both as individual products and as bundled lifestyle plans (Empowered+ and Thrive Forward). The ecosystem extends through the Brello Rise digital wellness studio (providing virtual fitness and nutrition classes), the Brello mobile app for care management and progress tracking, and the Project Longevity educational podcast. The company emphasizes a people-first approach supporting long-term health engagement alongside medical care.
Differentiator
Problem solved
Functional benefit
Brands
- Brello Rise: Digital wellness studio designed for individuals following medically supervised weight management programs, offering personalized wellness plans, meditation, functional fitness, Pilates, barre, and nutrition instruction.
- Project Longevity
Products and services
- Tirzepatide Compounded GLP-1 medication with B6 support for weight management. Subscription starting at $166/month with a 3-month minimum plan, includes provider review, ongoing support, syringes, injection instructions, virtual fitness and nutrition classes, and community access.
- Semaglutide Compounded GLP-1 medication for weight management. Subscription starting at $133/month, includes provider review, medication, syringes, injection instructions, fitness classes, and community access.
- NAD+ Compounded NAD+ medication for cellular energy and longevity support. Subscription starting at $79/month.
- Sermorelin Compounded Sermorelin peptide therapy delivered to the customer's door. Subscription starting at $116/month.
- MICC Compounded wellness medication (MICC formulation) offered as part of Brello's telehealth wellness medication lineup.
- Brello Rise Digital Wellness Studio Digital wellness studio offering personalized wellness plans, meditation, functional fitness, Pilates, barre, and nutrition instruction available on Apple TV, Fire TV, Roku TV, and Google TV. Included with wellness plan subscriptions.
- Brello Mobile App All-in-one mobile application for iOS and Android with HIPAA-secure messaging, dosage confirmation, medication logging, provider messaging, order cancellation, live shipping tracking, refill reminders, live chat support, and progress charts with motivational milestones.
Quantifiable outcome
- Weight loss results of 62 pounds in 6 months, 108 pounds in several months, and 59.1 pounds in 30 weeks reported by verified members
- +1 more outcomes
Companies that use Brello Health
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles2 records
Brello Health technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature4 records
Brello Health partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- AP Max, Inc. d/b/a Southend PharmacycorePrimary pharmacy partner handling prescription fulfillment. Medications are shipped directly to customers by this partner pharmacy. The pharmacy is transitioning to a new, larger facility to better serve customers. Shipping costs are included in professional fees when prescriptions are filled through the partner pharmacy.
Scale indicators4 records
Recent moves7 records
Expansion highlights6 records
Brello Health competitors and assessment
Company assessmentBroad incumbents
- LifeMD: Public telehealth company offering GLP-1 weight management alongside primary care, men's/women's health, and dermatology. Comparable in offering GLP-1 telehealth but operates at broader portfolio scale.
Direct peers
- Calibrate: Telehealth metabolic health platform combining GLP-1 prescriptions with coaching, app-based tracking, and community. Operates a near-identical model to Brello (medication + coaching + community) and competes for the same member.
- Found: DTC telehealth weight-loss platform prescribing compounded semaglutide and tirzepatide alongside behavior change coaching. Direct competitor in the cash-pay GLP-1 subscription category with similar target demographic.
- Noom (Noom Med): Established weight-management platform that expanded into telehealth GLP-1 prescribing via Noom Med. Comparable in weight-loss focus, though Noom's heritage is behavioral coaching versus Brello's prescription-first approach.
- Ro: DTC telehealth platform operating across weight management (Ro Body), men's/women's health, and pharmacy fulfillment. Offers compounded GLP-1s through a similar cash-pay subscription model with provider consultations and home delivery.
- Mochi Health: Telehealth platform specializing in weight management with compounded GLP-1 prescriptions, provider consultations, and ongoing support. Comparable in offering structure and target customer to Brello.
- Hims & Hers Health: Public DTC telehealth platform offering compounded GLP-1s (semaglutide, tirzepatide) alongside wellness and longevity products. Most directly comparable peer — same cash-pay subscription model, same core medications, similar bundled-content strategy at much larger scale.
- Henry Meds: DTC telehealth provider of compounded GLP-1 weight-loss programs with subscription pricing and home delivery. Closely comparable on product offering and business model to Brello's core program.
Emerging players
- Alpha Medical: Women's-focused DTC telehealth platform offering weight management and hormonal health consultations. Comparable audience and condition-specific care model, though smaller scale than Brello.
- WeightWatchers (WW Clinic): Legacy weight-management brand that added clinician-prescribed GLP-1 access through WW Clinic. Comparable in weight-loss focus; offers broader brand and member base but less specialized in compounded pharmacy fulfillment.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Brello Health social profiles
Digital presenceBrello Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Brello Health leadership team
Management profileNumber of profiles
Profiles1 record
Brello Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Brello Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Brello Health
What does Brello Health do?
Brello Health operates a direct-to-consumer telehealth platform that connects women with healthcare providers for clinician-prescribed compounded wellness medications, primarily GLP-1 agonists (Tirzepatide and Semaglutide), NAD+, and Sermorelin, which are shipped from a USA-based 503A partner pharmacy directly to the customer's door. The service is bundled with a mobile app for progress tracking and provider messaging, a digital wellness studio (Brello Rise) for virtual fitness and nutrition classes on major streaming platforms, and a private Facebook community for ongoing accountability.
Is Brello Health a public or private company?
Brello Health is a private company. It is classified as unknown and is currently operating.
When was Brello Health founded?
Brello Health was founded in 2023. It employs 101 to 250 people.
Where is Brello Health based?
Brello Health is headquartered in Houston, United States, in the North America region.
How does Brello Health make money?
Three revenue lines are on record. Wellness Medication Subscriptions are the primary driver. The others are bundled Care Plans and professional Fees.
Who are Brello Health's main competitors?
LifeMD is listed as a broad incumbent. Direct peers are Calibrate, Found, Noom (Noom Med), Ro, Mochi Health, Hims & Hers Health and Henry Meds. Emerging players are Alpha Medical and WeightWatchers (WW Clinic).
Does Brello Health have an API?
No public API is recorded for Brello Health.
What industry is Brello Health in?
Brello Health's product category is Telehealth Wellness Services. Its primary akta.pro industry code is HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription), with a secondary code of HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs). Its NAICS code is 456110 and its SIC code is 8011.